Literature DB >> 24784373

Monte Carlo simulation of TrueBeam flattening-filter-free beams using varian phase-space files: comparison with experimental data.

Maria F Belosi1, Miguel Rodriguez2, Antonella Fogliata1, Luca Cozzi1, Josep Sempau3, Alessandro Clivio1, Giorgia Nicolini1, Eugenio Vanetti1, Harald Krauss4, Catherine Khamphan5, Pascal Fenoglietto6, Josep Puxeu7, David Fedele8, Pietro Mancosu9, Lorenzo Brualla10.   

Abstract

PURPOSE: Phase-space files for Monte Carlo simulation of the Varian TrueBeam beams have been made available by Varian. The aim of this study is to evaluate the accuracy of the distributed phase-space files for flattening filter free (FFF) beams, against experimental measurements from ten TrueBeam Linacs.
METHODS: The phase-space files have been used as input in PRIMO, a recently released Monte Carlo program based on the PENELOPE code. Simulations of 6 and 10 MV FFF were computed in a virtual water phantom for field sizes 3 × 3, 6 × 6, and 10 × 10 cm(2) using 1 × 1 × 1 mm(3) voxels and for 20 × 20 and 40 × 40 cm(2) with 2 × 2 × 2 mm(3) voxels. The particles contained in the initial phase-space files were transported downstream to a plane just above the phantom surface, where a subsequent phase-space file was tallied. Particles were transported downstream this second phase-space file to the water phantom. Experimental data consisted of depth doses and profiles at five different depths acquired at SSD = 100 cm (seven datasets) and SSD = 90 cm (three datasets). Simulations and experimental data were compared in terms of dose difference. Gamma analysis was also performed using 1%, 1 mm and 2%, 2 mm criteria of dose-difference and distance-to-agreement, respectively. Additionally, the parameters characterizing the dose profiles of unflattened beams were evaluated for both measurements and simulations.
RESULTS: Analysis of depth dose curves showed that dose differences increased with increasing field size and depth; this effect might be partly motivated due to an underestimation of the primary beam energy used to compute the phase-space files. Average dose differences reached 1% for the largest field size. Lateral profiles presented dose differences well within 1% for fields up to 20 × 20 cm(2), while the discrepancy increased toward 2% in the 40 × 40 cm(2) cases. Gamma analysis resulted in an agreement of 100% when a 2%, 2 mm criterion was used, with the only exception of the 40 × 40 cm(2) field (∼95% agreement). With the more stringent criteria of 1%, 1 mm, the agreement reduced to almost 95% for field sizes up to 10 × 10 cm(2), worse for larger fields. Unflatness and slope FFF-specific parameters are in line with the possible energy underestimation of the simulated results relative to experimental data.
CONCLUSIONS: The agreement between Monte Carlo simulations and experimental data proved that the evaluated Varian phase-space files for FFF beams from TrueBeam can be used as radiation sources for accurate Monte Carlo dose estimation, especially for field sizes up to 10 × 10 cm(2), that is the range of field sizes mostly used in combination to the FFF, high dose rate beams.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24784373     DOI: 10.1118/1.4871041

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  13 in total

Review 1.  Monte Carlo systems used for treatment planning and dose verification.

Authors:  Lorenzo Brualla; Miguel Rodriguez; Antonio M Lallena
Journal:  Strahlenther Onkol       Date:  2016-11-25       Impact factor: 3.621

2.  Pixel Image Analysis and Its Application with an Alcohol-Based Liquid Scintillator for Particle Therapy.

Authors:  Ji-Won Choi; Ji-Young Choi; Hanil Jang; Kyung-Kwang Joo; Byoung-Chan Kim
Journal:  Sensors (Basel)       Date:  2022-06-28       Impact factor: 3.847

3.  Monte Carlo evaluation of target dose coverage in lung stereotactic body radiation therapy with flattening filter-free beams.

Authors:  Oleg N Vassiliev; Christine B Peterson; Joe Y Chang; Radhe Mohan
Journal:  J Radiother Pract       Date:  2020-10-16

4.  Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium.

Authors:  Oleg N Vassiliev; Stephen F Kry; He C Wang; Christine B Peterson; Joe Y Chang; Radhe Mohan
Journal:  Phys Med Biol       Date:  2018-09-28       Impact factor: 3.609

5.  Monte Carlo simulation using PRIMO code as a tool for checking the credibility of commissioning and quality assurance of 6 MV TrueBeam STx varian LINAC.

Authors:  M Arif Efendi; Amporn Funsian; Thawat Chittrakarn; Tripob Bhongsuwan
Journal:  Rep Pract Oncol Radiother       Date:  2019-12-20

6.  Monte Carlo simulation of beam characteristics from small fields based on TrueBeam flattening-filter-free mode.

Authors:  Zhongsu Feng; Haizhen Yue; Yibao Zhang; Hao Wu; Jinsheng Cheng; Xu Su
Journal:  Radiat Oncol       Date:  2016-02-27       Impact factor: 3.481

7.  Superficial and peripheral dose in compensator-based FFF beam IMRT.

Authors:  Daniel G Zhang; Vladimir Feygelman; Eduardo G Moros; Kujtim Latifi; Sarah Hoffe; Jessica Frakes; Geoffrey G Zhang
Journal:  J Appl Clin Med Phys       Date:  2016-12-21       Impact factor: 2.102

8.  Output factor comparison of Monte Carlo and measurement for Varian TrueBeam 6 MV and 10 MV flattening filter-free stereotactic radiosurgery system.

Authors:  Jason Y Cheng; Holly Ning; Barbara C Arora; Ying Zhuge; Robert W Miller
Journal:  J Appl Clin Med Phys       Date:  2016-05-08       Impact factor: 2.102

9.  Clinically relevant investigation of flattening filter-free skin dose.

Authors:  Christopher L Guy; Kishor Karki; Manju Sharma; Siyong Kim
Journal:  J Appl Clin Med Phys       Date:  2016-11-08       Impact factor: 2.102

10.  Feasibility of a GATE Monte Carlo platform in a clinical pretreatment QA system for VMAT treatment plans using TrueBeam with an HD120 multileaf collimator.

Authors:  Boram Lee; Seonghoon Jeong; Kwangzoo Chung; Myonggeun Yoon; Hee Chul Park; Youngyih Han; Sang Hoon Jung
Journal:  J Appl Clin Med Phys       Date:  2019-09-23       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.